GlassScriptPhysician profile
David P Schreiber
NPI 1154314227
$741.18
in general payments reported to CMS, 2019-2025
16 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $72.50 · 2021: $202 · 2022: $121 · 2023: $65.84 · 2024: $47.04 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $145.71 | 2020-2021 | |
| Tolmar Pharmaceuticals, INC. | $88.38 | 2019-2021 | |
| Janssen Biotech, INC. | $71.80 | 2019 | |
| Blue Earth Diagnostics | $64.30 | 2019-2022 | |
| Teleflex LLC | $54.38 | 2024-2025 | Barrigel |
| Amgen INC. | $44.55 | 2020-2022 | |
| Palette Life Sciences, INC. | $42.51 | 2022-2023 | |
| Myriad Genetic Laboratories, INC. | $39.99 | 2025 | Prolaris |
| Bioprotect Medical, INC. | $32.53 | 2025 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $27.96 | 2023 | |
| Angiodynamics, INC. | $27.51 | 2022 | |
| Pfizer INC. | $24.36 | 2025 | |
| Myovant Sciences Gmbh | $22.92 | 2022 | |
| Astellas Pharma US INC | $21.73 | 2024 | Xtandi |
| Tolmar, INC. | $19.39 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Schreiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.